Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about PURETECH HEALTH PLC
11/22 PURETECH HEALTH : to Present at Piper Jaffray 2017 Healthcare Conference
11/20 PURETECH HEALTH : resTORbio Advances Immunotherapy Candidate for Aging-Related C..
11/09 PURETECH HEALTH : to Present at Jefferies 2017 Healthcare Conference in London
11/03 PURETECH HEALTH : Vedanta Biosciences Awarded $5.4 Million Grant from Combating ..
11/03 VEDANTA BIOSCIENCES : Awarded Up To $5.4 Million from CARB-X to Accelerate Devel..
11/01 PURETECH HEALTH : Vedanta Licenses Microbiome-Derived Immuno-Oncology Product Ca..
11/01 VEDANTA BIOSCIENCES : to Advance Cancer Immunotherapy Candidates Based on Microb..
09/25 GELESIS : 100 Achieves Significant Weight Loss with Excellent Safety Profile in ..
09/25 PURETECH HEALTH : Gelesis Reports Significant Weight Loss with Excellent Safety ..
09/20 PURETECH HEALTH : Notes US Patent Issuance Broadly Covering Methods of Assessing..
09/20 PURETECH HEALTH : Notes U.S. Patent Issuance Broadly Covering Methods of Assessi..
08/29 PURETECH HEALTH : Exclusively Licenses Glyph Technology from Monash University t..
08/25PURETECH HEALTH PLC : half-yearly earnings release
08/15 PURETECH HEALTH : Notice of Half-Yearly Results
07/13 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
More most relevant news
All news about PURETECH HEALTH PLC
11/22 PURETECH HEALTH : to Present at Piper Jaffray 2017 Healthcare Conference
11/20 PURETECH HEALTH : resTORbio Advances Immunotherapy Candidate for Aging-Related C..
11/09 PURETECH HEALTH : Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to ..
11/09 PURETECH HEALTH : to Present at Jefferies 2017 Healthcare Conference in London
11/03 PURETECH HEALTH : Vedanta Biosciences Awarded $5.4 Million Grant from Combating ..
11/03 VEDANTA BIOSCIENCES : Awarded Up To $5.4 Million from CARB-X to Accelerate Devel..
11/01 PURETECH HEALTH : Vedanta Licenses Microbiome-Derived Immuno-Oncology Product Ca..
11/01 VEDANTA BIOSCIENCES : to Advance Cancer Immunotherapy Candidates Based on Microb..
09/28 PURETECH HEALTH : Notes U.S. Patent Issuance Broadly Covering Methods of Assessi..
09/25 GELESIS : 100 Achieves Significant Weight Loss with Excellent Safety Profile in ..
More news
Sector news : Biotechnology & Medical Research - NEC
11/22 U.S. FDA approves first two-drug HIV regimen in win for GSK
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Biotechnology & Medical Research - NEC
Financials ($)
Sales 2017 1,63 M
EBIT 2017 -120 M
Net income 2017 -97,2 M
Finance 2017 171 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 134x
EV / Sales 2018 97,8x
Capitalization 388 M
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,16 $
Spread / Average Target 93%
EPS Revisions
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Eric Elenko Chief-Research & Strategy
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC5.09%388
CELLTRION, INC.--.--%25 050
IQVIA HOLDINGS INC37.36%22 053
INCYTE CORPORATION5.19%20 882
LONZA GROUP59.15%19 928
ALNYLAM PHARMACEUTICALS, INC.240.57%12 981